Literature DB >> 17686837

Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses.

Patrick J Dillon1, Griffith D Parks.   

Abstract

Six amino acid substitutions in the shared N-terminal region of the P subunit of the viral polymerase and the accessory V protein convert the noncytopathic paramyxovirus simian virus 5 (SV5), which is a poor inducer of host cell responses, into a P/V mutant (P/V-CPI-) that induces high levels of apoptosis, interferon-beta (IFN-beta), and proinflammatory cytokines. In this study, we addressed the question of whether these new mutant phenotypes are due to the presence of an altered P protein or of an altered V protein or of both proteins. By the use of the P/V-CPI- mutant as a backbone, new mutant viruses were engineered to express the wild-type (WT) V protein (+V-wt) or WT P protein (+P-wt) from an additional gene inserted between the HN and L genes. In human epithelial cell lines, the +V-wt virus showed reduced activation of apoptosis and lower secretion of IFN-beta and proinflammatory cytokines compared to the parental P/V-CPI- virus. The presence of a V protein lacking the C-terminal cysteine-rich domain (corresponding to the SV5 I protein) did not reduce these host cell responses to P/V-CPI- infection. Unexpectedly, the +P-wt virus, which expressed a WT P subunit of the viral polymerase, also induced much lower levels of host cell responses than the parental P/V-CPI- mutant. For both +V-wt and +P-wt viruses, reduced levels of IFN-beta synthesis correlated with reduced IRF-3 dimerization and nuclear localization of IRF-3 and NF-kappaB, suggesting that the WT P and V proteins acted at an early stage in antiviral pathways. Host cell responses induced by the various P/V mutants directly correlated with levels of viral mRNA accumulation but not with steady-state levels of genomic RNA. Our results support the hypothesis that WT P and V proteins limit induction of antiviral responses by controlling the production of key viral inducers. A model is presented for the mechanism by which both the P subunit of the viral polymerase and the V accessory protein contribute to the ability of a paramyxovirus to limit activation of antiviral responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686837      PMCID: PMC2045556          DOI: 10.1128/JVI.01360-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  MULTIPLICATION OF A MYXOVIRUS (SV5) WITH MINIMAL CYTOPATHIC EFFECTS AND WITHOUT INTERFERENCE.

Authors:  P W CHOPPIN
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

Review 3.  Viral DNA polymerase scanning and the gymnastics of Sendai virus RNA synthesis.

Authors:  Daniel Kolakofsky; Philippe Le Mercier; Frédéric Iseni; Dominique Garcin
Journal:  Virology       Date:  2004-01-20       Impact factor: 3.616

Review 4.  Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein.

Authors:  Curt M Horvath
Journal:  Eur J Biochem       Date:  2004-12

5.  Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.

Authors:  D Garcin; P Latorre; D Kolakofsky
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics.

Authors:  J A Southern; D F Young; F Heaney; W K Baumgärtner; R E Randall
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

7.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.

Authors:  J Andrejeva; K S Childs; D F Young; T S Carlos; N Stock; S Goodbourn; R E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

8.  Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Apoptosis induction and interferon signaling but not IFN-beta promoter induction by an SV5 P/V mutant are rescued by coinfection with wild-type SV5.

Authors:  Elizabeth K Wansley; Jason M Grayson; Griffith D Parks
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

10.  Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5.

Authors:  S M Thomas; R A Lamb; R G Paterson
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  30 in total

Review 1.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

Review 2.  Emerging paramyxoviruses: molecular mechanisms and antiviral strategies.

Authors:  Hector C Aguilar; Benhur Lee
Journal:  Expert Rev Mol Med       Date:  2011-02-24       Impact factor: 5.600

Review 3.  Paramyxovirus activation and inhibition of innate immune responses.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Mol Biol       Date:  2013-09-20       Impact factor: 5.469

4.  A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.

Authors:  Maria D Gainey; Mary J Manuse; Griffith D Parks
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

5.  Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction.

Authors:  M J Killip; D F Young; D Gatherer; C S Ross; J A L Short; A J Davison; S Goodbourn; R E Randall
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

6.  TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5.

Authors:  Mary J Manuse; Griffith D Parks
Journal:  Virology       Date:  2009-11-30       Impact factor: 3.616

7.  Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function.

Authors:  Subhashini Arimilli; John B Johnson; Kimberly M Clark; Aaron H Graff; Martha A Alexander-Miller; Steven B Mizel; Griffith D Parks
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  Phosphorylation of measles virus nucleoprotein affects viral growth by changing gene expression and genomic RNA stability.

Authors:  Akihiro Sugai; Hiroki Sato; Misako Yoneda; Chieko Kai
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

9.  Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.

Authors:  Raychel Chambers; Toru Takimoto
Journal:  J Gen Virol       Date:  2009-05-07       Impact factor: 3.891

10.  Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist.

Authors:  D F Young; M C Galiano; K Lemon; Y-H Chen; J Andrejeva; W P Duprex; B K Rima; R E Randall
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.